Full Recovery of Sensorineural Hearing Loss in a Patient with Congenital Hypothyroidism.

IF 1 4区 医学 Q3 AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY
Journal of the American Academy of Audiology Pub Date : 2023-10-01 Epub Date: 2023-09-01 DOI:10.1055/a-2165-0789
Jacline G Phillips, Samantha B Fabian, Erin W Adkins, Eleanor P Kiell
{"title":"Full Recovery of Sensorineural Hearing Loss in a Patient with Congenital Hypothyroidism.","authors":"Jacline G Phillips, Samantha B Fabian, Erin W Adkins, Eleanor P Kiell","doi":"10.1055/a-2165-0789","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong> Congenital hypothyroidism (CH) is one of the most preventable causes of intellectual disability in the world. Screening programs have led to earlier detection of CH, and children with adequate thyroid supplementation can have minor long-term differences in overall neuropsychological testing compared to baseline.</p><p><strong>Purpose: </strong> Despite early identification, up to one-fourth of children born with CH suffer from hearing loss even with early and adequate thyroid hormone supplementation. We present a unique case of an individual born with congenital hypothyroidism found to have sensorineural hearing loss.</p><p><strong>Research design: </strong> Case report.</p><p><strong>Study sample: </strong> Single subject.</p><p><strong>Intervention: </strong> Diagnosis of congenital hypothyroidism at 1 week of life and initiation of treatment with levothyroxine.</p><p><strong>Data collection and analysis: </strong> Degree of hearing loss was measured with age-appropriate audiological testing at ages 4 weeks, 7 weeks, 3 months, 7 months, 9 months, 11 months, and 12 months.</p><p><strong>Results: </strong> The patient was treated early with thyroid hormone supplementation and demonstrated full recovery of hearing by age 12 months.</p><p><strong>Conclusions: </strong> Despite the body of literature documenting hearing loss as an ongoing complication of CH, this patient demonstrates a unique case of full hearing recovery with early treatment.</p>","PeriodicalId":50021,"journal":{"name":"Journal of the American Academy of Audiology","volume":" ","pages":"225-229"},"PeriodicalIF":1.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Audiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2165-0789","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background:  Congenital hypothyroidism (CH) is one of the most preventable causes of intellectual disability in the world. Screening programs have led to earlier detection of CH, and children with adequate thyroid supplementation can have minor long-term differences in overall neuropsychological testing compared to baseline.

Purpose:  Despite early identification, up to one-fourth of children born with CH suffer from hearing loss even with early and adequate thyroid hormone supplementation. We present a unique case of an individual born with congenital hypothyroidism found to have sensorineural hearing loss.

Research design:  Case report.

Study sample:  Single subject.

Intervention:  Diagnosis of congenital hypothyroidism at 1 week of life and initiation of treatment with levothyroxine.

Data collection and analysis:  Degree of hearing loss was measured with age-appropriate audiological testing at ages 4 weeks, 7 weeks, 3 months, 7 months, 9 months, 11 months, and 12 months.

Results:  The patient was treated early with thyroid hormone supplementation and demonstrated full recovery of hearing by age 12 months.

Conclusions:  Despite the body of literature documenting hearing loss as an ongoing complication of CH, this patient demonstrates a unique case of full hearing recovery with early treatment.

先天性甲状腺功能减退症患者感音神经性听力损失的完全恢复。
背景:先天性甲状腺功能减退症(CH)是世界上最容易预防的智力残疾原因之一。筛查项目导致早期发现CH,与基线相比,补充足够甲状腺的儿童在整体神经心理测试中有轻微的长期差异。目的:尽管早期发现,高达四分之一的先天性CH患儿即使早期补充足够的甲状腺激素也会遭受听力损失。我们提出了一个独特的情况下,个人出生先天性甲状腺功能减退症发现有感觉神经性听力损失。研究设计:病例报告。研究样本:单一受试者。干预:出生1周后诊断为先天性甲状腺功能减退并开始左旋甲状腺素治疗。数据收集和分析:在4周、7周、3个月、7个月、9个月、11个月和12个月时采用适龄听力学测试测量听力损失程度。结果:患者早期接受甲状腺激素补充治疗,12个月时听力完全恢复。结论:尽管有大量文献记载听力损失是CH的持续并发症,但该患者是一个通过早期治疗完全恢复听力的独特病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
0.00%
发文量
46
审稿时长
6-12 weeks
期刊介绍: The Journal of the American Academy of Audiology (JAAA) is the Academy''s scholarly peer-reviewed publication, issued 10 times per year and available to Academy members as a benefit of membership. The JAAA publishes articles and clinical reports in all areas of audiology, including audiological assessment, amplification, aural habilitation and rehabilitation, auditory electrophysiology, vestibular assessment, and hearing science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信